Veru secures $100M via equity offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
14,978$
4,81%
Echtzeit-Aktienkurs Veru Inc.
Bid:
14,859$
Ask:
15,096$
Nachrichten zur Veru Inc. Aktie
Veru Announces Pricing of Public Offering of Common Stock
MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…
Veru Announces Proposed Public Offering of Common Stock
MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…
VERU INC.: 10-Q Report
10-Q...…
Thinking about trading options or stock in Moderna, Tilray, Lyft, Under Armour, or Veru?
NEW YORK , Feb. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA,…
Female Health Company The (VERU) Reports Q1 Loss, Tops Revenue Estimates
Female Health Company The (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December…
Veru EPS in-line, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter
--Q1 FY21 Net Revenues and Gross Profit of $15M and $11M, Respectively, Achieve New Historical Highs for Second Consecutive Quarter--…
Why Veru Stock Surged Today
Analysts are excited about the potential of the biotechs experimental COVID-19 treatment....…
Veru Leaps on Progress With COVID-19 Treatment Trial
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru CEO says cancer drug has potential to prevent Covid-19 deaths
Veru CEO Dr. Mitchell Steiner explained how VERU-111, a prostate cancer drug developed by the biotech company, could be used…
Veru CEO discusses clinical results of prostate cancer drug being studied to treat Covid-19
Veru CEO Dr. Mitchell Steiner joined Jim Cramer on "Mad Money" to break down findings from a Phase 2 clinical…
Why Veru Stock Is Skyrocketing Today
The company reported great results from a phase 2 study in treating hospitalized COVID-19 patients....…
Thinking about buying stock in Ocugen, Westport Fuel Systems, Purple Biotech, TherapeuticsMD, or Veru?
NEW YORK , Feb. 8, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…
Veru posts positive phase 2 study results of VERU-111 in hospitalized COVID-19 patients
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
– Potential for two-pronged action against COVID-19 as an antiviral and anti-inflammatory agent supported by…
T2 Biosystems, Zomedica leads healthcare gainers; Pro-Dex, Veru among major losers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th
MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…
Is The Rally In Veru Overdone?
After a stellar 3x rise since the March 23 levels of last year, at the current price of around $10…
Veru to Present at the H.C. Wainwright Bioconnect 2021 Conference on January 11th, 2021
MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…
Veru Inc.: Robust Oncology Drug Pipeline Driving Bullish Momentum
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru stock price target raised to $19 from $9 at Oppenheimer
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Implied Volatility Surging for Veru (VERU) Stock Options
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately....…
Thinking about buying stock in Anavex Life Sciences, Veru Inc, vTv Therapeutics, BioCardia, or 22nd Century Group?
NEW YORK , Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…
Veru CEO on developing drug prostate cancer and breast cancer
Veru CEO Michael Steiner joined Jim Cramer on "Mad Money" to discuss data behind the oncology biopharmaceutical company's study of…
Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals?
NEW YORK , Dec. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE,…
Veru Reports Positive Phase 2 Clinical Trial Results for Enobosarm, Selective Androgen Receptor Targeting Agent, for Endocrine Resistant Metastatic Breast Cancer
-- Phase 2 Multicenter, International Clinical Study Selected as Spotlight Presentation at 2020 San Antonio Breast Cancer Symposium –...…
VERU-111, Cytoskeleton Disruptor, Demonstrates Efficacy in Preclinical Models of Human Triple Negative Breast Cancer
-- Preclinical Data Presented at the 2020 San Antonio Breast Cancer Symposium-- -- VERU-111 has Anticancer Activity in Both Paclitaxel…
Veru soars as HC Wainwright sees value from enobosarm addition
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
VERU INC.: 10-K Report
10-K...…
Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?
NEW YORK , Dec. 10, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE,…
Veru Inc. (VERU) Q4 2020 Earnings Call Transcript
VERU earnings call for the period ending September 30, 2020....…
Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru in-licenses late-stage androgen receptor targeted therapy for breast cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Recap: Veru Q4 Earnings
Shares of Veru (NASDAQ:VERU) moved higher by 4.2% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share…
Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer
--Transformation to Premium Oncology Biopharmaceutical Company with Late-Stage Clinical Drug Pipeline Focused on Prostate and Breast Cancer is Complete-- --Company…
Veru EPS misses by $0.13, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru Reports Record Fiscal 2020 Fourth Quarter and Record Full-Year Financial Results
—FY20 Full-Year Net Revenues and Gross Profit Achieve Historical Highs of $43 Million and $31 Million, Respectively—...…
Veru: The Russell 2000 is a good indicator for the reopening of the economy
Dan Veru of Palisade Capital Management discusses how small cap, as reflected by the Russell 2000, is a good measurement…
ROUNDUP 3: Hongkonger Aktivist Joshua Wong muss mehr als ein Jahr ins Gefängnis
(neu: Zitat von Wong im 5. Absatz)HONGKONG (dpa-AFX) - Der prominente Hongkonger Demokratie-Aktivist Joshua Wong und zwei seiner Mitstreiter sind…
IS-Terrormiliz greift Ölraffinerie im Nordirak an - keine Opfer
BAGDAD (dpa-AFX) - Die Terrormiliz Islamischer Staat (IS) hat nahe der strategisch wichtigen Stadt Baidschi im Nordirak eine kleine Ölraffinerie…
Veru to Report Fiscal 2020 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 9th
MIAMI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with…
Neuer Impuls für klimaneutrale Bundesverwaltung
Das Bundesumweltministerium hat eine neue Koordinierungsstelle eingerichtet, die die Pläne voranbringen soll, dass alle Bundesbehörden bis 2030 klimaneutral werden.…
Veru enrolls in Phase 2 trial for an oral drug for metastatic prostate cancer
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru Completes Enrollment of Phase 2 Clinical Trial of VERU-111, Novel Oral Drug for Metastatic Prostate Cancer
MIAMI, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with…
Veru (VERU) Presents At Morgan Stanley 18th Annual Global Healthcare Conference
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Veru: The shift from the heavy cap-weighted names to a more broadening out of the market is underwy
Dan Veru of Palisade Capital Management discusses how a pickup in the broader market, outside of mega-cap tech and work-from…
Veru Announces ESMO Congress 2020 Oral Presentation of Positive Clinical Results from its VERU-111 Phase 1b Study in Metastatic Prostate Cancer
—Advancing VERU-111 to a Pivotal Phase 3 Clinical Program—...…
Veru to Participate and Present at Four Upcoming Healthcare Investor Conferences
MIAMI, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with…
Veru: The Russell 200 has emerged as the reopening benchmark
Dan Veru, co-chairman and chief investment officer at Palisade Capital Management, talks about markets amid a rally in equities, pointing…